As part of the Laws that Learn series, Kenneth Oye (MIT) and Professor Arti Rai (Duke) will discuss the challenges and opportunities in shifting the way the U.S. Food and Drug Administration, and its counterparts around the world, regulate pharmaceutical products. The current system calls for a one-time decision to approve a drug in general. Can and should we move from that system to a sequential process of partial approvals with continued monitoring and learning? How can our regulatory systems incorporate continued learning as new technologies and their impacts emerge?
This event is cosponsored by the Center for Innovation Policy at Duke Law, the Rethinking Regulation Program at the Kenan Institute for Ethics, and the Nicholas Institute for Environmental Policy Solutions at Duke.